Amgen Inc. buy Royal Bank of Canada
Start price
05.08.26
/
50%
€337.30
Target price
05.08.27
€346.72
Performance (%)
5.37%
Price
07.08.26
€355.40
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 5.37%. This prediction currently runs until 05.08.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amgen Inc. | 5.37% |
| iShares Core DAX® | 2,57 % |
| iShares Nasdaq 100 | 4,86 % |
| iShares Nikkei 225® | 5,59 % |
| iShares S&P 500 | 3,25 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $370.00 to $400.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat